文献速递内脏/肾动脉与血管畸形

单支动脉慢性肠系膜缺血患者血运重建后症状持续缓解

Persistent symptom relief after revascularization in patients with single-artery chronic mesenteric ischemia.
PubMed 文献 · J Vasc Surg · 2018-03-06

回顾性队列分析59例有胃肠道症状且单支肠系膜动脉狭窄、经黏膜缺血检查转诊的患者,37例获慢性肠系膜缺血(CMI)多学科共识诊断并接受血运重建。平均随访5.0±3.0年,27/37例(73%)症状持续缓解,缓解与病变位置无关(腹腔干73% vs 肠系膜上动脉71%,P=.919)。

要点

  • 单支腹腔干或肠系膜上动脉狭窄伴胃肠道症状者中,37/59例获CMI共识诊断。
  • 血运重建后平均随访5.0±3.0年,73%(27/37)患者症状持续缓解。
  • 症状缓解与病变位置无关(腹腔干73% vs 肠系膜上动脉71%,P=.919)。

核心结论

  • 对因单支动脉粥样硬化性肠系膜动脉狭窄诊断为CMI的患者,腹腔干或肠系膜上动脉血运重建可使73%的患者获得持续症状缓解。

研究设计与样本

  • 回顾性队列分析,纳入2006年至2010年间转诊至三级医疗机构的59例有胃肠道症状且单支肠系膜动脉粥样硬化性狭窄、接受CMI标准化诊断评估(包括可见光光谱或胃-空肠测压法测定黏膜缺血)的连续患者。
  • 59例中37例获CMI多学科共识诊断并接受开放手术或血管腔内血运重建。

主要发现

  • 37例中孤立性腹腔干狭窄30例(81%),孤立性肠系膜上动脉狭窄7例。
  • 平均随访5.0±3.0年,27/37例(73%)血运重建后症状持续缓解。
  • 症状缓解与病变位置无关:腹腔干73% vs 肠系膜上动脉71%,P=.919。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: An isolated stenosis of the celiac artery (CA) or the superior mesenteric artery (SMA) is frequently detected in patients with abdominal complaints. The dilemma is whether these patients suffer from chronic mesenteric ischemia (CMI) and whether they will benefit from revascularization. We evaluated the long-term clinical success rates for single CA or SMA revascularization in patients with gastrointestinal symptoms and confirmed mucosal ischemia. METHODS: This was a retrospective cohort analysis of 59 consecutive patients with gastrointestinal symptoms and a single atherosclerotic mesenteric artery stenosis who were referred to our tertiary care institution between 2006 and 2010 for standardized diagnostic workup of CMI, including measurement of mucosal ischemia with visible light spectroscopy or gastric-jejunal tonometry. Patients with multidisciplinary consensus diagnosis of CMI underwent surgical or endovascular revascularization. The primary outcome was clinical response to revascularization, defined as relief of presenting symptoms as experienced by the patient. RESULTS: Consensus diagnosis of CMI was obtained in 37 of 59 patients. Isolated CA stenosis was present in 30 of 37 patients (81%) and isolated SMA stenosis in seven patients. After a mean follow-up of 5.0 ± 3.0 years, 27 of 37 patients (73%) experienced sustained symptom relief after revascularization. Response was not related to lesion localization (CA, 73%; SMA, 71%; P = .919). CONCLUSIONS: Revascularization of the CA or SMA provides persistent symptom relief in 73% of patients diagnosed with CMI due to single atherosclerotic mesenteric artery stenosis.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. van Dijk LJD, Moons LMG, van Noord D, et al. Persistent symptom relief after revascularization in patients with single-artery chronic mesenteric ischemia. J Vasc Surg. 2018. PMID: 29523436. doi:10.1016/j.jvs.2017.12.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。